Writing

Writing on product systems, fintech infrastructure, market behavior, and leadership lessons from practical execution.

📚 Books

Beyond platform leadership and infrastructure design, I write about trading psychology, financial literacy, and structured market participation.

Both books are published globally on Amazon (Kindle & Paperback editions available).

🟦 The Mind Game of Trading

Mastering Psychology for Consistent Profits
By Sreenivasulu Malkari

Overview

Trading success is rarely limited by strategy. It is limited by psychology.

In The Mind Game of Trading, I distill 15+ years of real-world trading experience into a structured framework for mastering discipline, emotional control, and execution integrity.

The book focuses on:

• Identifying hidden cognitive biases
• Structured journaling & checklist systems
• Emotional risk management
• Practical trading plan templates
• Long-term consistency frameworks

This is not a theory book — it is a practical discipline manual for traders at all levels.

🔗 Available on Amazon (Paperback & Kindle)
👉 https://www.amazon.com/dp/B0FNKGB7W2

🟦 The Stock Market Starter Kit

Learn to Trade Smart in 7 Days
By Sreenivasulu Malkari

Overview

Designed for beginners entering the Indian stock market, this book simplifies complex concepts into a structured 7-day learning framework.

It emphasizes structured thinking, capital protection, and long-term consistency as the core pillars of intelligent market participation.

It covers:

• How stock markets function (NSE/BSE context)
• Intraday, swing & long-term trading basics
• Risk management principles
• Chart reading fundamentals
• Practical checklists and action plans

Clear. Structured. Actionable.

🔗 Available on Amazon (Paperback & Kindle)
👉 https://www.amazon.com/dp/B0FF2NK8MV



  • Orkla India IPO: Prioritizing Dividend Over Growth Capital

    Orkla India IPO: A Hefty Dividend Payout Ahead of Listing Just days before its upcoming initial public offering (IPO), MTR Foods’ parent company, Orkla India Ltd., distributed a hefty Rs 600-crore dividend for fiscal 2025 — its first-ever dividend payout in 17 years and one that exceeds the company’s annual profits for any previous year.…


  • Coforge Q2 Results: Profit Surges 18% with Interim Dividend Declaration

    Coforge Q2 Results: A Comprehensive Analysis Coforge, a leading IT services company, has announced its Q2 results, showcasing an impressive 18% rise in profit. The company has also declared an interim dividend of Rs 4 per share, demonstrating its commitment to rewarding shareholders. In this article, we will delve into the details of Coforge’s Q2…


  • Defence Stocks in India: Antique Bullish on BEL, HAL, and Others

    Defence Stocks in India: A Promising Sector The Indian defence sector has been gaining traction in recent years, driven by the government’s efforts to promote domestic manufacturing and reduce dependence on imports. The Defence Acquisition Council’s (DAC) approval of capital procurement proposals worth Rs 79,000 crore has further boosted the sentiment for defence stocks in…


  • Utkarsh Small Finance Bank Shares Soar 18% After Share Allotment to Madhusudan Kela’s Fund House

    Utkarsh Small Finance Bank Shares Jump 18% After Share Allotment to Madhusudan Kela’s Fund House The shares of Utkarsh Small Finance Bank ended the session on Friday with 18% gains after it rose nearly 20% after the lender announced that it has allotted over 5.71 crore shares to investor Madhusudan Kela’s fund house Madhusudan Kela‘s…


  • Bharat Rasayan Announces 1:1 Bonus Share Issue and Stock Split: What Investors Need to Know

    Bharat Rasayan Gets Board Nod For 1:1 Bonus Share Issue, Stock Split Bharat Rasayan Ltd.’s board of directors approved a 1:1 issue of bonus share along with a share split, according to an exchange filing on Friday. This move is expected to increase the liquidity of the company’s shares and make them more attractive to…


  • Dr Reddy’s Q2 Results: Profit Rises 7% On Sharp Climb In Europe Business

    Dr Reddy’s Q2 Results: Profit Rises 7% On Sharp Climb In Europe Business Dr Reddy’s Laboratories Ltd.’s profit in the second quarter of this financial year rose 7.3% to Rs 1,347 crore in the quarter ended September. This is in comparison to a profit of Rs 1,256 crore in the same quarter of the previous…


Scroll to Top